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Abstract 
Menopause is the time in a woman’s life when regular menstrual periods cease, 
due to a natural change in sex hormones, which may be accompanied by unwelcome 
symptoms. PURPOSE: To determine whether physical activity is associated with a 
reduction in menopausal symptoms (hot flashes, insomnia, numbness, fatigue, headaches, 
psychological symptoms, urogenital symptoms and physical symptoms). Providing that 
symptom differences among activity levels exist, a secondary purpose was to suggest an 
adequate level of physical activity for relief of menopausal symptoms. METHODS: 
Women (n=401) who were not taking hormone replacement therapy completed two 
questionnaires based on a 7-day recall of an average week: the Leisure-Time Exercise 
Questionnaire (Godin & Shephard, 1985) and the Menopausal Index (St. Germain, 
Peterson, Robinson, & Alekel, 2001). Women were divided into quintiles according to 
their physical activity scores (1=least active, 5=most active) and compared for 
menopausal symptoms using first a MANCOVA with covariate percent fat, as this was 
the only covariate that had significant group mean differences. Secondly a MANOVA 
with the appropriate post-hoc analysis was conducted. RESULTS: The mean (SD) age of 
the participants was 58.2 (6.3), the mean years postmenopausal was 6.7 (6.0), the mean 
percent body fat was 37.4 (5.6) %, and 16.5% had a previous hysterectomy. Univariate 
tests did not identify significant group differences for hysterectomy (p=0.774) or time 
since menopause (p=0.440); however, there were significant group differences for 
percent body fat (p=0). The MANCOVA was not significant between physical activity 
groups with percent fat as a covariate (Wilks’ Lamda p = 0.126).  The MANOVA 
indicated a significant group main effect of physical activity on menopausal symptoms 
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(Wilks’ Lamda p = 0.034). Of the 8 symptoms under review there were significant group 
differences for fatigue (p=0.05), and physical symptoms (p=0.004). The post-hoc 
analyses identified that two least active groups reported above average fatigue occurrence 
whereas the three most active groups reported below average fatigue occurrence. Group 2 
had significantly more physical symptom complaints than groups 4 & 5. Of the three 
symptoms comprising physical symptoms, there were significant differences for weight 
gain (p=0.004) but not for breast tenderness (p=0.742) or aches and pains (p=0.175). 
Groups 1 & 2 reported significantly higher frequency of weight gain than groups 4 & 5. 
CONCLUSION: Any indirect effect of physical activity on menopausal symptoms is 
most likely through the alteration of body composition. Women with lower percent body 
fat report less weight gain and fatigue. There was no significant relationship between 
physical activity levels and reporting of hot flashes/night sweats, insomnia, limb 
numbness, headache, psychological symptoms or urogenital symptoms. A randomized 
controlled clinical trial would likely determine the relationship between higher activity 
levels and symptom reduction. For future research it is recommended that groups be 
matched based on percent body fat prior to randomization and that a greater amount of 
physical activity be prescribed.  
 
 
 
iii 
Acknowledgements 
I would like to thank my advisor Dr. Philip Chilibeck, for his continuing support 
throughout this research process. I would also like to thank my committee members: Dr. 
Larry Brawley, Dr. Bob Faulkner and my external examiner, Dr. Angela Busch for their 
advice and guidance. 
I would also like to acknowledge the Canadian Institute of Health Research for 
funding, the Saskatoon Health Region and my colleague Denise Cornish. Thank you to 
all of the postmenopausal women who participated in this study. 
Finally, I would like to offer a special thank you to my mom Jacqueline Hounjet, 
who taught me the importance of hard work and perseverance and to my partner Ryan 
Strate whose support has been invaluable. 
iv 
TABLE OF CONTENTS 
 Page # 
 
PERMISSION TO USE 
 
 
ii 
ABSTRACT 
 
ii 
ACKNOWLEDGEMENTS 
 
iv 
TABLE OF CONTENTS 
 
v 
LIST OF APPENDICES 
 
vii 
CHAPTER 1 1 
1.1 Introduction 
 
1 
1.2 Review of the literature 
 
5 
     1.2.1   Clinical Trials  
 
10 
1.3 Effect of exercise on individual menopausal symptoms  
 
13 
1.3.1   Hot flashes and Night Sweats 
 
13 
1.3.2 Headache 
 
14 
1.3.3 Sleep Problems 
 
15 
1.3.4 Fatigue 
 
16 
1.3.5 Limb numbness 
 
17 
1.3.6 Psychological Symptoms 
 
17 
1.3.7 Physical Symptoms 
 
18 
1.3.8 Urogenital Symptoms 
 
19 
1.3.9 Co-Factors 
 
1.3.10 Summary 
 
20 
 
21 
v 
 
1.4   Statement of Purpose 
 
23 
1.4.1 Hypothesis 23 
 
CHAPTER 2 – METHODOLOGY 24 
2.1 Research Design 
 
24 
     2.1.1   Participants  
 
24 
2.1.2 Sample Size 
 
25 
2.2   Measures 26 
2.2.1 Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985 
 
26 
     2.2.2   Menopausal Index (St. Germain et al., 2001) 27 
     2.2.3   Body Composition 28 
2.3 Procedures 29 
2.4 Analysis 32 
CHAPTER 3 – RESULTS 34 
CHAPTER 4 – DISCUSSION 41 
4.1   Conclusion 46 
4.2   Limitations 46 
4.3   Future Directions 48 
REFERENCES 49 
APPENDICES 57 
 
vi 
LIST OF APPENDICES 
APPENDIX A: Inclusion Checklist 
APPENDIX B: Consent Form and Certificate of Approval 
APPENDIX C: Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985) 
APPENDIX D: Menopausal Index (St. Germain et al., 2001) 
APPENDIX E: Personal Information Form 
APPENDIX F: SPSS Output 
APPENDIX G: Literature Review Grid Table 
  
vii 
CHAPTER 1 
1.1 Introduction 
According to the Society of Obstetricians and Gynecologists of Canada (2006), 
the average age of menopause is 51 years. Year 2011 is when the first generation of 
baby-boomers will reach the age of 65. From 2011 until the year 2031 Canada’s 
population will rapidly age and it is predicted that by 2031, 25% of Canada’s population 
will be 65 years or older (Statistics Canada, 2005); thus, there will be a considerable 
number of menopausal women. The rising number of women dealing with menopausal 
symptoms could result in many women living with a decrease in quality of life; therefore, 
educating women on ways to cope with menopause would be beneficial. 
Menopause is the time in a woman’s life when regular menstrual periods cease, 
due to a natural change in sex hormones. A woman is considered to be postmenopausal 
after she has gone twelve consecutive months without menstruating.  
Up to 75% of American women will experience unwelcome menopausal 
symptoms such as hot flashes during the menopausal transition (Avis, Crawford, & 
McKinley, 1997). Other symptoms may include: insomnia (Owens & Mathews, 1998), 
limb numbness, fatigue (Oldenhave, Jaszmann, Haspels, & Everaerd, 1993), headache 
(Oldenhave et al., 1993), psychological complaints (Asbury, Chandrruangphen, & 
Collins, 2006), urogenital complaints (Dennerstein, Randolph, Taffe, Dudley, & Burger, 
2002) and physical complaints (Haines, Xing, Park, Holinka, & Ausmanase, 2005). One 
of the most common menopausal symptoms is hot flashes or night sweats that result from 
a sudden surge of heat throughout the body that may cause profuse sweating. Hot flashes 
are often referred to as vasomotor symptoms because of the dilation of blood vessels. 
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Fortunately, for most women menopausal symptoms such as hot flashes will abate within 
6 months to 2 years (Kronenberg, 1990).  Up to 85% of women will experience hot 
flashes for more than a year (Kletsky & Borenstein, 1987) whereas only 20% will 
experience symptoms for 10-20 years (Berg, Gottwall, Hammar, & Lindgren, 1988).  
The menopausal transition may also be associated with irritability, tension, 
fatigue, headaches, muscle/joint pain and sometimes depression (Oldenhave et al., 1993). 
Sleep tends to be disrupted by night sweats (Hunter & Liao, 1996), and disrupted sleep 
can alter daily activities, which may lead to fatigue, irritability, and decreased quality of 
life (Greendale & Sowers, 1997).  
Some longer-term outcomes of this hormonal change include urogenital 
symptoms (Modelska & Cummings, 2003). Urogenital symptoms can include vaginal 
dryness, uncomfortable intercourse, reduction in sexual desire or libido and urinary 
incontinence.  Vaginal atrophy occurs as estrogen levels drop which results in the 
thinning of the vaginal epithelium, which may result in vaginal dryness, itching and/or 
burning (Willhite & O’Connell, 2001).  An outcome of vaginal atrophy is that women 
may feel pain with intercourse, which can lead to avoidance of sexual activity and affect 
quality of life (Johnston et al., 2004). Vaginal dryness has been estimated to occur in 17% 
to 30% of postmenopausal women (Nelson et al., 2005) and 10% to 50% of 
postmenopausal women experience urinary incontinence (Larson, Collings, & Landgren, 
1997). A community based survey with 16,065 pre to post menopausal women identified 
that urine leakage was more common among women with higher body mass index (BMI) 
and was not associated with age in late perimenopause or postmenopause (Gold et al., 
2000). Nelson et al. (2005) conducted a literature review attempting to distinguish 
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between symptoms that were associated with the menopausal transition or simply of 
ageing. This literature review of 48 studies identified that urinary complaints were 
inconsistently associated with menopause. 
Women who undergo surgical menopause (hysterectomy and/or oophectomy) 
experience a rapid drop in gonadal hormones and are more likely to have symptoms such 
as sexual dysfunction, psychological problems and more frequent and intense hot flashes 
(Kotz, Alexander, & Dennerstein, 2006; Sherwin & Gelfand, 1985). The occurrence of 
hot flashes has been reported at rates of up to 90% for women who undergo bilateral 
oophorectomy (Feldman, Voda, & Gronseth, 1985). 
There is an increase in BMI with age, or more particularly body fat, with the peak 
BMI occurring between ages 50 and 59 (Kuczmarski, Flegal, Campbell, & Johnson, 
1994). This is important to note since the timing coincides with post menopause. The 
relationship between BMI and vasomotor symptoms is unclear. Some research has shown 
that higher BMI is related to increased symptom reporting whereas others have shown the 
opposite, and others have found no relationship between BMI and menopausal symptoms 
(Schwingl, Hulka, & Harlow, 1994; Ivarsson, Spetz, & Hammar, 1998; Gold et al., 2006; 
Longcope, 1979; Erlik, Meldrum, & Judd, 1982; Gold et al., 2000, Chiechi et al., 1997; 
Freeman et al., 2001; and Mirzaiinjmabadi, Anderson, & Barnes, 2006). 
At one time the leading treatment for menopause-related symptoms was hormone 
replacement therapy (HRT).  Hormone replacement therapy is effective in the 
management of hot flashes; however, it has been suggested that it may pose a higher risk 
for breast cancer (Goodman et al., 1997; Collaborative Group on Hormonal Factors in 
Breast Cancer, 1997). Li and Holm (2003) found that the combination of HRT and 
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exercise was more effective than HRT or exercise alone for reducing vasomotor 
symptoms.  
Physical activity has repeatedly been shown to have many health benefits in 
various populations including those in the menopause transition. The Canadian physical 
activity guide for older adults recommends getting at least 30-60 minutes of moderate 
intensity of physical activity on most days (PHAC, 2007). The Centre for Disease 
Control and Prevention suggests a minimum of 60 minutes per day to prevent weight gain 
(CDCP, 2007). In menopausal and postmenopausal age women, studies have shown that 
exercise has beneficial effects on mood (Slaven & Lee 1997), quality of life (Villaverde-
Gutierrez et al., 2006), body composition (Sternfeld, Bhat, Wang, Sharp, & Quesenberry, 
2005), strength, balance (Aloia, McGowan, Vaswani, Ross, & Cohn, 1991), aerobic 
fitness (Bloomfeld et al., 1993) and menopausal symptoms (McMillan & Mark, 2004; 
Slaven & Lee, 1997; Villaverde-Gutierrez et al., 2006; Li & Holm, 2003; Carmody, 
Crawford, & Churchill, 2006). The purpose of this research project was to determine 
whether reports of higher levels of physical activity are associated with reduced reporting 
of menopausal symptoms in a very specific population of non-vigorously active 
postmenopausal women, who were not taking hormone replacement therapy. Exercise 
has many positive health benefits and may be an inexpensive treatment for relief of 
menopausal symptoms. This study is unique in that it has very tight inclusion criteria, and 
possible confounding variables were considered including: years since last menstrual 
period, hysterectomy and percent body fat. The exclusion of women who were very 
physically active narrows the activity levels between groups allowing for a closer 
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prediction on the amount of physical activity necessary for the relief of menopausal 
symptoms.  
 
1.2 Review of the Literature 
Results from a number of cross-sectional studies have suggested that physical 
activity is beneficial for improving some menopausal symptoms but not others (Gold et 
al., 2000; Progetto Menopausa Italia Study Group, 2005, Ivarsson et al., 1998; Stadberg, 
Mattisson, & Milsom, 2000; Guthrie, Dennerstein, Taffe, Lehert, & Burger, 2005). The 
age range of women studied in the current menopausal literature is wide, ranging from 
the mid 30’s into the 60’s. The sample populations among studies are also largely 
variable, making it difficult to compare findings between studies. There are many cross-
sectional studies and few clinical trials therefore it is difficult to derive any cause-effect 
relationship between higher activity levels and reduced symptoms. The measurement of 
activity levels and menopausal symptoms has been tested with various tools, making it 
difficult to compare studies against one another. Some studies failed to control for 
important co-factors (i.e. time since menopause, HRT, hysterectomies) that may affect 
the presence of menopausal symptoms. A weakness of most studies that did find an effect 
of physical activity is that they do not define the amount of physical activity required to 
relieve symptoms; therefore, an exercise prescription for inactive women is difficult to 
derive from these studies.  
Results from the most current study on the relationship between physical activity 
and menopausal symptoms showed that high levels of physical activity are related to 
reduced stress but not vasomotor symptoms (Nelson, Sammel, Freeman, Lin, Gracia, & 
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Schmitz, 2007). The required amount of activity required to reduce stress was translated 
into walking 4.0 mph for 1.5 hours, 5 times per week. Nelson et al. (2007) suggested that 
maintaining or increasing physical activity during the menopausal transitional and during 
postmenopause may assist in reducing a variety of psychological symptoms, including 
anxiety, stress, and depression. During the course of this non-randomized prospective 
observational study spanning over an 8-year period, participants (N= 380, ages 35-47 at 
intake) completed self-reported questionnaires on depression, anxiety, stress and physical 
activity. A weakness of this study is that activity reports were only taken every second 
year and there were large fluctuations in activity levels between assessment periods. The 
authors were concerned with the accuracy of using physical activity reports at one 
assessment to predict symptoms in the next assessment period. 
The Progetto Menopausa Italia Study Group (2005) conducted a large study on 
menopausal symptoms and activity levels. It was a cross-sectional study with a sample 
size of 66,501 women. They found that women attending menopausal treatment clinics, 
who performed regular exercise, experienced less frequent depression, headache, urinary 
leakage, irritability, hot flashes/night sweats, forgetfulness and difficulty to sleep. A 
relationship between activity levels and BMI was identified where women who did 
minimal physical activity had a higher BMI than women who performed regular physical 
activity. This study accounted for HRT use, presence of hysterectomy and menopausal 
status, however is not representative of an average Italian population. All women 
sampled in this study were seeking advice for menopause-related problems therefore may 
have had higher symptom complaints or may have been more health conscious than the 
average population. 
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Another large cross-sectional study by Gold et al. (2000) sampled 12,425 women 
of multiple ethnicities. The researchers found that women with BMI over 32 kg/m2 had a 
higher prevalence of hot flashes/night sweats, urine leakage, vaginal dryness, sleep 
difficulty, stiff/soreness and forgetfulness than women with a BMI less than 19 kg/m2. In 
this study, physical activity was assessed with a single question about activity levels 
relative to other women of similar age; finding significant differences in symptom 
reporting among women who did much less or much more physical activity than women 
of similar age. The differences between those who did much less versus those who did 
much more was as follows: hot flashes/night sweats 52.5% vs 32.6%, urine leakage 
29.8% vs 13.6%, vaginal dryness 21.6% vs 11.9%, sleep difficulty 60.8% vs 31.2%, 
stiff/soreness 73.1% vs 46.8%, and forgetfulness 56.9% vs 33.5%.  
In 2006, Mirzaiinjmabadi et al. examined the relationship between exercise and 
BMI on menopausal symptoms of 886 women between the ages of 45-60. Results from 
this cross-sectional study showed that exercise was effective in relieving psychological 
symptoms, tiredness, headache and limb numbness however identified no relationship 
between exercise and vasomotor symptoms or sexual symptoms. The researchers found 
no relationship between BMI and menopausal symptoms. Strength of this study is that 
confounding variables such as HRT use, menopausal status, education and smoking 
status were accounted for. Ivarsson et al. (1998) in a cross-sectional study of 793 
postmenopausal women found that only 4.8% of women who exercised more than 2 
hours per week reported severe vasomotor symptoms, whereas 14-16% of inactive 
women reported severe vasomotor symptoms. This study initially divided women into 3 
activity levels based on self-reports; however the researchers chose to collapse the non-
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exercising and the intermediate group comparing 84 exercisers against 256 non-
exercisers. They found that it was not the type of activity that differentiated symptom 
reporting, but the intensity of activity.   
Stadberg et al. (2000) (N=4,504) investigated factors associated with climacteric 
symptoms and the use of HRT. They randomly mailed out a survey to Swedish women 
between the ages of 42-62 years. This cross-sectional study identified a correlation 
between lower levels of vasomotor symptoms and regular exercise. The researchers 
reported that 69% of 54 year olds experienced hot flashes, and that 50% of 62 year olds 
were still experiencing vasomotor symptoms. Fifty two percent of the 4,504 women 
reported sleeping problems and 37% reported decreased libido. Although this study 
included information on associations between physical activity and menopausal 
symptoms, its primary purpose was not to examine the effects of exercise on symptoms 
but to identify all factors associated with symptoms and the use of HRT. 
Guthrie et al. (2005) (N=381) investigated factors associated with the presence, 
severity, and frequency of hot flashes, reporting similar findings to Stadberg et al. (2000) 
where women who did less than average amounts of exercise were more likely to report 
bothersome hot flashes. They also reported that as women grew further from menopause, 
hot flashes became less of a problem. This 9-year prospective observational study did not 
find an association between BMI and hot flashes. Menopause status, age, exercise level, 
and smoking status all contributed to the experience of bothersome hot flashes. The 
sampled population had better self-rated health and exercise habits than reported by the 
general Australian population 
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Slaven and Lee (1997) conducted two cross-sectional studies. The first study 
included 220 women who were pre, peri or postmenopausal comparing exercisers to non-
exercisers. Results showed that exercisers report fewer symptoms than non-exercisers 
and that exercising menopausal women experience less menopausal distress than 
sedentary menopausal women. The second study (N=47) found enhancements in mood 
regardless of menopausal status and reduction in reported menopausal symptoms 
(depressed mood, memory, concentration, anxiety, sexual dysfunction, sleep problems, 
irritability, head ache and depression) immediately following an aerobic fitness class 
when compared to non-exercisers. Although exercisers reported fewer somatic symptoms 
than non-exercisers there were no significant difference in reports of vasomotor 
symptoms between exercisers and non-exercisers. 
Li et al. (2003) in a population based survey of 6,917 Swedish women between 
the ages of 50 and 64 identified that vigorous physical activity was associated with less 
vaginal dryness and lower intensity flashes. Weight gain and a BMI ranging from 25 to 
29.9, were associated with a higher incidence of hot flashes. It was reported that weight 
gain increased the risk of hot flashes by 30% to 38%. Li et al. (2003) suggested that 
menopausal symptoms might commence earlier and be of longer duration in obese 
women. Although associations were made between physical activity and menopausal 
symptoms, physical activity was not identified as an independent factor for reducing 
menopausal symptoms. 
These cross-sectional studies identified associations between higher activity levels 
and a reduction of hot flashes (Li et al., 2003; Ivarsson et al., 1998; Guthrie et al., 2005; 
Stadberg et al., 2000; Progetto Menopausa Italia Study Group, 2005), vaginal dryness (Li 
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et al., 2003), tiredness, headache, limb numbness (Mirzaiinjmabadi et al., 2006), 
psychologically-related symptoms (Nelson et al., 2007; Slaven & Lee, 1997; Progetto 
Menopausa Italia Study Group, 2005; Mirzaiinjmabadi et al., 2006) and some reported no 
change in vasomotor symptoms (Nelson et al., 2007, Slaven & Lee, 1997; 
Mirzaiinjmabadi et al., 2006). Li et al. (2003) identified that PA was not an independent 
factor for reducing menopausal symptoms and the menopausal literature often examines 
differences in BMI and its associations with menopausal symptoms. Some studies have 
identified that weight gain and elevated BMI are associated with higher incidence of 
vasomotor symptoms (Li et al., 2003; Gold et al., 2000) whereas others have reported no 
association between BMI and vasomotor symptoms (Guthrie et al., 2005; 
Mirzaiinjmabadi et al., 2006).  
 
1.2.1 Clinical Trials 
The following studies describe exercise interventions and whether exercise had an 
effect on menopausal symptoms. The strongest evidence for an effect of exercise on 
menopausal symptoms can be derived from intervention studies.  
Aiello et al. (2004) conducted a randomized clinical trial looking at the effect of 
moderate intensity exercise on the frequency and severity of menopausal symptoms in 
postmenopausal women. The average age of the participants was 61 years; all women 
were overweight and were not taking HRT.  Half of the women (N=87) completed 
cardiovascular training such as walking, aerobics or cycling 5 days per week for a total of 
225 minutes weekly for 12 months. The control group (N=86) performed stretching 
exercises. Their findings showed no differences in menopausal symptoms between the 
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stretching and cardiovascular training groups. A small number of the study participants in 
the cardiovascular intervention actually reported an increase in frequency and severity of 
some menopausal symptoms, but some showed a reduction in memory problems (Aiello 
et al. 2004). Since the average age of menopause is 51 years (Obstetricians and 
Gynecologists of Canada, 2006) and most women only experience hot flashes for 6 
months to 2 years, (Kronenberg 1990) it is likely that many of the women studied would 
no longer experience symptoms; therefore it might be difficult to see a relationship with 
physical activity. 
Elavsky and McAuley (2007) conducted a randomized clinical trial with 164 
sedentary women ages 42-58 years on the effects of a 4-month walking (3 times per 
week) or yoga (2 times per week) intervention on mental health and menopause related 
quality of life (QOL), including sleep quality. The two exercise groups were compared to 
a control group who did not change their inactive behaviors. The results identified 
reduced vasomotor symptom reporting in both of the exercise groups, with a greater 
effect for the women in the walking group versus women in the yoga group. The control 
group demonstrated very little change in vasomotor symptoms indicating that the effect 
for the exercise groups was not due to passage of time. Within the same sample, both the 
walking and yoga interventions were found to be ineffective for improvements in sleep 
quality. Elavsky and McAuley (2007) stated that their study lacked sufficient power and 
that research with larger samples was warranted. The questionnaire used in that study was 
very long which may have affected the way in which participants responded. A shorter, 
yet detailed and precise questionnaire may be less of a burden for participants to 
complete and reduce the number of statistical tests required for analysis.  
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Villaverde-Gutierrez et al. (2006) examined the effects of physical exercise on 
QOL in 48 menopausal women between the ages of 55 and 72 years with a quasi-
experimental analytical design. Half of the women acted as controls and the other half 
were assigned to an activity group that included cardiovascular training, stretching, 
strength and relaxation exercise 2 times per week for one year. Women in the exercise 
group showed an improvement in menopausal symptoms and health related QOL, 
whereas the symptoms and health related QOL of those in the control group worsened. 
This study reported a decrease in menopausal symptoms from 50% to 37.5% using the 
Kupperman-Blatt Menopausal Index as their measurement tool (the study in this thesis 
used a modified version of this index).  However they failed to mention which symptoms 
were examined and which showed the most dramatic decrease. 
Two of the three clinical trials identified that regular exercise reduces menopausal 
symptoms including vasomotor symptoms but not sleep problems (Elavsky & McAuley, 
2007) and improves QOL (Villaverde-Gutierrez et al., 2006). However one of the three 
trials contradicted these finding showing no association between regular exercise and 
symptom reduction (Aiello et al., 2004). Therefore more research in the area of exercise 
and menopausal symptoms is needed. See appendix G for the literature review grid table.  
The subsequent sections in this review of literature examine each of the 
menopausal symptoms from the above-mentioned Kupperman-Blatt Menopausal Index 
and the possible effect that physical activity may have on these symptoms. 
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1.3   Effect of exercise on individual menopausal symptoms 
1.3.1 Hot flashes and Night Sweats 
Exercise may play a role in the reduction of hot flashes and night sweats 
(Hammer, Berg, & Lindgren, 1990). Hot flashes or night sweats are often referred to as 
vasomotor symptoms because the hormonal change that occurs in menopausal women 
interrupts the norepinephrine and dopamine neurotransmitter balance, which leads to 
vasomotor instability (Ostrzenski, 1999). It is thought that hot flashes originate from the 
hypothalamus and are associated with a decline in estrogen levels (Speroff et al., 1999). 
As estrogen levels decrease in postmenopausal women, there is also a reduction in 
hypothalamic opioids, such as beta-endorphins (Hammar, Hammar-Henriksson, Frisk, 
Rickenlund, & Wyon, 2000).  Reduction of beta-endorphins causes dysfunction of the 
body’s thermoregulatory centre, which has been postulated to be the cause of hot flashes 
(Shanafelt, Barton, Adjei, & Loprinzi, 2002). Since postmenopausal women have lower 
beta-endorphin concentrations than fertile women (Nappi et al., 1990), and since exercise 
increases beta-endorphin release in the central nervous system and in the peripheries 
(Schwartz & Kindermann, 1992; Andersson & Lundeberg, 1995), exercise may help to 
stabilize thermoregulation (Ivarsson et al., 1998; Hammer et al., 1990). This could 
explain the reduced frequency and intensity of hot flashes with increased physical 
activity.  It is also possible that women who exercise regularly are accustomed to and 
comfortable with the feeling of being hot and sweaty; therefore they report hot flashes to 
be less intense (Ivarsson et al., 1998).  
Body Mass Index has been related to vasomotor symptoms in some studies but 
not all (Schwingl et al., 1994; Mirzaiinjmabadi et al., 2006; Ivarsson et al., 1998; Gold et 
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al., 2006, Guthrie et al., 2005). Some data suggests that heavier women report fewer hot 
flashes resulting from a fat-related increase in circulating estrone (Longcope, 1979; Erlik 
et al., 1982; Schwingl et al., 1994); whereas others such as Gold et al. (2000) found that 
hot flashes or night sweats were reported more frequently in women with a BMI greater 
than 27 kg/m2. Conversely, others have reported no difference between hot flash 
frequencies in women with high and low BMI (Ivarsson et al., 1998; Mirzaiinjmabadi et 
al., 2006). Gold et al. (2006) found that those with excessive body mass had more 
vasomotor symptoms. Chiechi et al. (1997) and Freeman et al. (2001) also found that 
heavier women reported more hot flashes because they had more insulation and therefore 
a narrower thermoneutral zone. A thermoneutral zone is the range of ambient 
temperatures where one does not have to actively regulate body temperature through 
raising or slowing metabolism. Body mass index increases with age, peaking between 50 
and 59 years (Kuczmarski et al., 1994). Exercise may help in the maintenance of optimal 
body composition, body fat distribution, and slow weight gain (Sternfeld et al., 2005). 
The effects of physical activity for relieving hot flashes may therefore be through its 
effects on body composition. This will be determined by considering percent body fat as 
a confounding variable in the analysis of the relationship of physical activity with 
menopausal symptoms. 
 
1.3.2 Headache 
Similarly to hot flashes or night sweats, headaches during menopause may be 
triggered by fluctuations in estrogen levels (Marcus, 1994). Since exercise has been 
shown to result in a temporary increase of cortical blood flow and an increase of beta-
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endorphin release (Oleson, 1971) it may dull or numb headache pain. Tension headaches 
are more commonly reported among sedentary individuals, in which exercise may be a 
viable preventative treatment (Steiner, Fontebasso, & Del Brutto, 2002). Tension 
headaches are often related to muscle tightness in the neck or prolonged periods in one 
position and stretching and relaxation exercise may reduce their occurrence. Many 
studies with menopausal women have found associations between higher activity reports 
and fewer headaches (Li, Holm, Gulanick, Lanuza, & Penckofer, 1998; Mirzaiinjmabadi 
et al., 2006; Progetto Menopausa Italia Study Group, 2005; Slaven & Lee, 1997).  
 
1.3.3 Sleep Problems 
Up to 40% to 60% of perimenopausal and postmenopausal women experience 
sleep disturbance (Nelson et al., 2005), including symptoms such as waking too early, 
difficulty falling asleep and difficulty staying asleep. Despite the strong link of increase 
sleep problems being reported around the time of menopause, it is inconsistently reported 
as being associated with the menopausal transition (Nelson et al., 2005). Sleep 
disturbance is a common symptom of depression. Exercise may have an antidepressant 
and anti-anxiety effect thus may promote sleep (Youngstedt & Freelove-Charton, 2005). 
From another perspective, women with poor sleep quality may be more prone to 
depression; therefore, would report more frequent or severe menopausal symptoms, and 
as a result, may also participate in less physical activity (Elavsky & McAuley, 2007). 
Owens and Mathews (1998) found that women with higher waist to hip ratios reported 
higher frequency of difficulty falling asleep. They also found that women with disturbed 
sleep have a higher occurrence of joint pain. Studies with older adults have shown that 
15 
exercise may have a beneficial effect on sleep (Driver & Taylor, 2000) by increasing the 
duration of slow wave sleep (Youngstedt, O’Connor, & Dishman, 1997). It has been 
found that for postmenopausal women, 4 exercise sessions per week for 4 months 
reduced time to fall asleep by nearly half and increased sleep duration by nearly an hour 
(King, Oman, Brassington, Bliwise, & Haskell, 1997). Exercise may also have a 
beneficial effect on sleep by reducing anxiety and boosting mood state (O’Connor, 
Raglin, & Martinsen, 2000). A literature review by Youngstedt and Freelove-Charton 
(2005) proposed mechanisms by which exercise could promote sleep that included: 
anxiety reduction, antidepressant effects, thermogenic effect and circadian phase-shifting 
effect. Studies with menopausal women identified that higher activity levels reduced 
difficulty falling asleep (Progetto Menopausa Italia Study Group, 2005), and reduced 
sleep problems (Slaven & Lee, 1997) however one study reported that exercise failed to 
improve sleep quality (Elavsky & McAuley, 2007).  Another study found that 
postmenopausal women who do regular morning exercise have less trouble falling asleep 
(Tworoger et al., 2003). This study consisted of a year-long intervention where 
participants either did moderate intensity exercise or low intensity stretching, finding that 
increased fitness is associated with improved sleep, and that evening exercisers had more 
difficulty falling asleep. 
 
1.3.4 Fatigue 
Sleep deprivation is associated with increased fatigue and low energy levels. 
Inactivity induces muscular catabolism, which may negatively affect performance; 
therefore, more effort is required to carry out daily activities (Dimeo, Rumberger & Keul, 
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1998). An aerobic training program can break this cycle of lack of exercise, impaired 
performance, and easy fatigability (Dimeo et al., 1998). Fatigue can be associated with 
night sweats (Oldenhave et al., 1993), as sleep may be interrupted leading to fatigue. 
Mirzaiinjmabadi et al. (2006) found a positive relationship between exercise and reduced 
tiredness in postmenopausal women. 
 
1.3.5 Limb numbness 
Limb numbness or a feeling of pins and needles in the limbs can be associated 
with poor blood circulation. It is commonly accepted that exercise increases cardiac 
output and vasodilation, which increases blood circulation to get oxygen to the working 
muscles. One might guess that performing regular exercise such as walking or swimming 
may increase blood circulation and reduce limb numbness. A community-based study of 
women (mean age = 64.9) with back and leg pain identified that women with limb 
numbness participated in less physical activity (Vogt, Lauerman, Chirumbole, & Kuller, 
2002). Although this study related exercise to a reduction in limb numbness, this was not 
a study concerning menopausal symptoms. Limb numbness is not described as a 
symptom in the menopausal literature; it may be more related to ageing or to inactivity. 
One study with postmenopausal women did report fewer incidence of limb numbness 
among exercisers when compared to non-exercisers (Mirzaiinjmabadi et al., 2006). 
  
1.3.6 Psychological Symptoms 
Up to 50% of women attending menopause clinics report psychological 
complaints during the menopausal transition (Hay, Bancroft, & Johnstone, 1994). 
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Physical activity influences neurotransmitter release, which plays a major role in 
depressive symptoms (Juarbe, Guti´errez, Gilliss & Lee, 2006). Vance, Wadley, Ball, 
Roenker & Rizzo (2005) found that physical activity boosts cognitive function by 
promoting social interaction in older adults. They also found that participating in more 
physical activity predicted larger social networks, which can increase brain stimulation, 
thus indirectly lower depressive symptoms. Elavsky and McAuley (2007) found that 
exercisers had enhanced mood and improved menopause-related quality of life. 
Moderate-intensity exercise can stimulate a positive change in psychological health and 
quality of life among healthy postmenopausal women. However, in order to sustain this 
improved psychological health, exercise participation must be maintained in previously 
inactive postmenopausal women (Asbury et al., 2006). Other researchers have also 
identified positive correlations between exercise and reduced psychological symptoms 
during menopause (Mirzaiinjmabadi et al., 2006; Nelson et al., 2007; Progetto 
Menopausa Italia Study Group, 2005; Slaven & Lee, 1997). A literature review by Dunn, 
Trivedi, and O’Neal (2001) identified that both moderate and vigorous exercise can 
reduce symptoms of depression. 
 
1.3.7 Physical Symptoms 
Physical symptoms such as breast tenderness are specifically related to the 
hormonal changes during the menopausal transition; however, there is no research on 
whether exercise reduces the frequency of breast tenderness in postmenopausal women. 
Another physical symptom is aches and pains in the muscles and joints. A study 
conducted with 1028 postmenopausal women found that 86% of women reported body or 
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joint aches and pains (Haines et al., 2005). Myer et al. (1999) found a 54% reduction in 
aches and pains in a group of men and women between 40-97 years who participated in a 
community exercise program. One might speculate that aches and pains are reduced by 
the exercise induced beta-endorphin release, or it could be that since exercise reduces 
depressive symptoms (Vance et al., 2005) women are less likely to complain of body 
aches and pains.  
Another physical symptom associated with menopause is weight gain. Physical 
activity may provide a low-risk way of preventing weight gain and promoting 
maintenance of weight loss in overweight and obese women (Pronk & Wing, 1994). 
Sedentary postmenopausal women who exercised for approximately 3 hours a week for a 
year lost 4.2% of total body fat while maintaining their usual diet (Irwin et al., 2003). 
Sternfeld et al. (2005) determined that exercise is beneficial for maintaining optimal body 
composition in postmenopausal women. 
 
1.3.8 Urogenital Symptoms 
 Menopause is associated with a decline in sexual activity (Stadberg et al., 2000). 
Dennerstein et al. (2002) found that 42% of women in the early menopausal transition 
reported sexual dysfunction, compared with an alarming 88% of postmenopausal women. 
It is not clear how physical activity affects sexual health although; since physical activity 
improves fitness levels it may improve sexual health (Li et al., 1998). Physical activity 
has been shown to slow the rate of aging (Dziura, de Leon, Kasl & DiPietro, 2003), and 
may reduce weight gain therefore it may reduce sexual dysfunction by maintaining 
positive body image and sense of well-being. Ojanlatva et al. (2006) found that women 
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aged 42 to 46 (premenopausal age) who participated in strenuous exercise had more 
positive orgasmic experiences. However this study did not report increase positive 
orgasmic experiences in strenuous exercising women ages 52 to 56 (postmenopausal 
age). Slaven and Lee (1997) indicated that menopausal women reported less sexual 
dysfunction immediately following an aerobic exercise class. Li et al. (2003) found lower 
reports of vaginal dryness in exercising postmenopausal women. Conversely 
Mirzaiinjmabadi et al. (2006) found no association between exercise and sexual 
problems. 
Urinary stress incontinence is another commonly reported urogenital symptom 
and can occur as a result of vaginal atrophy and weakened muscles. The Progetto 
Menopausa Italia Study Group (2005) identified that regular exercise is associated with 
reduced reporting of urinary leakage. 
 
1.3.9 Co-Factors 
Time since menopause, hysterectomy and percent body fat were selected as 
possible co-factors in the study in this thesis because they are all thought to affect the 
frequency of menopausal symptoms. Time since menopause is a factor since most 
women will only experience menopausal symptoms such as hot flashes for 6 months to 2 
years (Kronenberg, 1990).  Only 20% will experience symptoms for 10-20 years (Berg et 
al., 1988). Hysterectomy is thought to be a factor since surgical menopause has been 
associated with greater frequency of hot flashes, sexual dysfunction, and psychological 
problems (Sherwin & Gelfand, 1985; Kotz et al., 2006). Hot flashes have been reported at 
rates of up to 90% for women who have both ovaries removed (Feldman et al., 1985). As 
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the ovaries are the primary producer of estrogen, the removal of these hormone-
producing glands causes an instant decrease in circulating estrogen. As for percent body 
fat, some say that heavier women report fewer hot flashes (Longcope, 1979; Erlik et al., 
1982; Schwingl et al., 1994); whereas others found that hot flashes or night sweats were 
reported more frequently in heavier women (Gold et al., 2000; Chiechi et al., 1997; 
Freeman et al., 2001; Li et al., 2003). Some have reported no difference between hot flash 
frequencies in women with high and low BMI (Ivarsson et al., 1998; Mirzaiinjmabadi et 
al. 2006; Guthrie et al., 2005). 
 
1.3.10 Summary 
There is evidence both supporting and refuting the effects of exercise on 
menopausal symptoms. Some studies suggest that higher activity levels reduce the 
number of vasomotor symptoms (Progetto Menopausa Italia Study Group, 2005; 
Stadberg et al., 2000; Guthrie et al., 2005; Li et al., 2003; Elavsky & McAuley, 2007) 
whereas others do not (Nelson et al., 2007; Mirzaiinjmabadi et al., 2006). Exercise has 
also been shown to reduce sleep problems (Progetto Menopausa Italia Study Group, 
2005; Slaven & Lee, 1997; Elavsky & McAuley, 2007), limb numbness and tiredness 
(Mirzaiinjmabadi et al., 2006), headache (Progetto Menopausa Italia Study Group, 2005; 
Mirzaiinjmabadi et al., 2006; Slaven & Lee, 1997) psychological problems 
(Mirzaiinjmabadi et al., 2006; Slaven & Lee, 1997; Nelson et al., 2007; Progetto 
Menopausa Italia Study Group, 2005) and urogenital symptoms (Progetto Menopausa 
Italia Study Group, 2005; Slaven & Lee, 1997; Li et al., 2003). 
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No studies have precisely defined the minimal level of physical activity that is 
required to reduce menopausal symptoms. With the study described in this thesis, women 
who reported doing vigorous activity were excluded. This provides a narrow range of 
physical activity levels, allowing for suggestion of the minimal level of activity required 
for reducing menopausal symptoms.  
This research project will examine whether reports of higher levels of physical 
activity are associated with reduced reporting of menopausal symptoms in a population 
base that is very specific to non-vigorously active postmenopausal. According to Health 
Canada reports, 60% of older adults are inactive (Health Canada, 2003). Exercise has 
many positive health benefits and may be an inexpensive treatment for relief of 
menopausal symptoms. This study is unique in that it has very tight inclusion criteria, and 
when appropriate adjustments will be made for possible confounding variables such as 
years since last menstrual period, hysterectomy and percent body fat. The Menopausal 
Index used in this study is detailed and specific to the most common menopausal 
symptoms; yet it is precise and quick to complete making it more likely for women to 
respond with accuracy. Since little research has been conducted in the area of exercise 
and its effects on menopausal symptoms this thesis is exploratory in nature. 
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1.4 Statement of the Purpose 
This thesis is based upon secondary data analysis from a data set for a clinical 
trial and it is a cross-sectional design. The main purpose was to determine whether 
physical activity was associated with a reduction in menopausal symptoms. Providing 
that a difference among groups exists, a secondary purpose was to suggest an adequate 
level of physical activity for relief of menopausal symptoms. 
 
1.4.1 Hypotheses 
It was hypothesized that among this sample of inactive women, those who are the 
most physically active will have fewer menopausal symptoms than those who are the 
least physically active.  
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CHAPTER 2 – METHODOLOGY 
2.1 Research Design 
 A cross-sectional observational design was used to explore menopausal symptom 
variation between women with differing activity levels. One of the inclusion criteria was 
that women could not be currently participating in vigorous physical activity; therefore 
the levels of physical activity were similar among women. Five physical activity groups 
were derived by dividing women based on self-reported levels of participation in physical 
activity. 
 
2.1.1 Participants 
Four hundred and one non-vigorously active postmenopausal women were 
recruited by newspaper ads and posters; and were required to meet the inclusion criteria 
(Appendix A). All subjects were postmenopausal defined by no menstrual period for at 
least 12 consecutive months. Women who were less than 2 years postmenopausal, or who 
had hysterectomies and were unsure of their menopausal status, were assessed for follicle 
stimulating and leutinizing hormone to confirm menopausal status. Subjects were not 
taking hormone replacement therapy or selective estrogen receptor modulators within 12 
months of recruitment. Subjects were not involved in vigorous exercise (such as running, 
high impact aerobic activities and/or weight training) at the time of recruitment. 
Additional exclusion criteria are outlined in Appendix A as these criteria were derived for 
a clinical trial that was determining the effects of an exercise and dietary intervention on 
bone mineral density. Baseline results from the clinical trial were used in this study (prior 
to the administration of exercise or dietary supplements) to examine the relationship 
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between activity levels and menopausal symptoms. The study was approved by the 
University of Saskatchewan’s Biomedical Research Ethics Board (Appendix B). Written 
informed consent (Appendix B) was obtained from all subjects prior to participation.  
 
2.1.2 Sample Size 
The minimum sample size was calculated using the mean and standard deviation 
of hot flashes and night sweats from the St. Germaine (2001) article (the questionnaire 
we chose to use). These were the only 2 symptoms with means and SD reported.  
The estimated mean (SD) for hot flash frequency from St-Germaine et al. (2001) 
showed their control group to have 32 hot flashes per week (SD= 5) and 9 night sweats 
per week (SD= 2). Elavsky and McAuley (2007) showed decreases in vasomotor 
symptoms for subjects in a walking exercise program to be 17% and 6% for control 
subjects. The expected change scores were used to calculate how different a physically 
active group might be from a control group for both hot flash frequency and night sweat 
frequency. Using the mean values from the St-Germaine et al. (2001) paper. The sample 
size calculations were done according the procedures of Elashoff (1999) as follows: The 
physical activity group expected hot flash frequency = 32 - (32 x 0.17) = 26.6 and the 
control group expected hot flash frequency = 32 - (32 x 0.06) = 30.1. Subjects were 
divided into quintiles based on their physical activity scores.  Based on this division it 
would be expected that three "intermediate physically active" groups would fall 
somewhere in-between the “physically active” and “control” values calculated above; 
therefore, assuming the improvement in vasomotor symptoms is linear across the groups, 
the estimated hot flash frequency for the intermediate groups would be 27.5, 28.4, and 
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29.2 from most active to least active. Using these estimated means of 5 physical activity 
groups and the SD of 5, an alpha of 0.05 and a power of 80% it was estimated that 41 
subjects per group (i.e. 205 subjects total) would be required for the study. 
 The same calculations were used for night sweats: The physical activity group 
night sweat frequency = 9 - (9 x 0.17) = 7.5 and the control group night sweat frequency 
= 9 - (9 x 0.06) = 8.5. Intermediately active groups would have a value between these two 
= 7.75, 8.0, and 8.25. Using these means and the SD of 2, an alpha of 0.05 and a power of 
80% it was estimated that 78 subjects per group (i.e. 390 subjects total) would be 
required.  
 
2.2 Measures 
The primary measurement tools used included the Leisure-Time Exercise 
Questionnaire (Godin & Shephard, 1985) and the Menopausal Index (St. Germain et al., 
2001). Both questionnaires are based on a 7-day recall of an average week. The third 
measurement tool used to assess body composition was dual energy X-Ray 
absorptiometry. 
 
2.2.1 Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985) (Appendix C) 
The Leisure-Time Exercise Questionnaire (LTEQ) is commonly used as an 
assessment tool for health and exercise related research. It was primarily developed and 
validated for an adult population. This self-administered questionnaire asks about the 
frequency of strenuous, moderate and mild intensity exercise activity performed for more 
than 15 minutes during free time of an average 7-day period. The intensity of activity is 
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weighted by anticipated metabolic equivalent (MET) values. The frequency of reported 
strenuous, moderate and mild intensity exercise sessions of more than 15 minutes are 
multiplied by 9, 5 and 3, respectively. The multiplied totals for respective intensities of 
exercise are then summed to provide an overall activity score. Test-retest reliability on 
the LTEQ with adults has been reported to be r=0.74 with a 2-week wait between re-
testing, and r=0.62 with a month between re-testing (Godin & Shepard, 1985; Jacobs, 
Ainsworth, Hartman & Leon, 1993). The LTEQ significantly correlates with 
accelerometer motion scores (r=0.32), and to VO2 Max (r= 0.56) (Jacobs et al., 1993). 
Sallis, Buono, Roby, Micale and Nelson (1993) compared the activity rating score to 
other activity measures showing significant correlation coefficients of r= 0.32 for the 
activity score and r=0.39 for the amount of calories burned per day. The LTEQ is 
comparable to other physical activity questionnaires for reliability but is one of the best 
for validity (Pereira et al., 1997). This questionnaire was also chosen because of its ease 
of administration and the fact that it takes only a minute to complete. Participants in this 
thesis were involved in a larger intervention study that included many other measures; 
therefore, this relatively short physical activity questionnaire was partly chosen to limit 
subject burden. 
 
2.2.2 Menopausal Index (St. Germain et al., 2001) (Appendix D) 
The second measurement tool was the Menopausal Index (St. Germain et al., 
2001). It considers frequency, duration and severity of various menopausal symptoms 
experienced during an average 7-day period. The symptoms under examination include 
hot flashes or night sweats, insomnia, limb numbness (pins and needles), fatigue and 
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headaches. It also includes a series of yes/no questions with sections on psychologically 
related areas (i.e. mood changes, depression, irritability, anxiety, and decrease 
concentration), urogenital symptoms (i.e. decreased sexual libido, vaginal dryness, 
uncomfortable intercourse, changes in urinary frequency), and physical symptoms (aches 
and pains in the back, muscles, and joints, breast tenderness, and weight gain).  
The Menopausal Index (St. Germain et al., 2001) was modified from the 
Kuppermann-Blatt Menopausal index (Blatt, Wiesbader & Kuppermann, 1953), which 
originally included a checklist of 11 symptoms. St. Germain et al. (2001) added another 6 
symptoms to capture the effects of vaginal atrophy. Reliability of the Kupperman-Blatt 
Menopausal index (Blatt et al., 1953) is r=0.68 (Sousa R.L., Sousa, E.S., Silva &  
Filizola, 2000).  Similar to the LTEQ, this questionnaire was chosen because of its ease 
and time of administration, limiting subject burden.  
 
2.2.3 Body Composition 
Body fat was assessed by dual X-ray absorptiometry whole body scans in array 
mode (Hologic Discovery). Participants lay supine on the X-ray bed, while the bed 
motioned up and down under the X-ray arm. The length of a full body scan is 
approximately 8 minutes. A reproducibility study was conducted on this machine 
measuring 18 women on two occasions, one week apart showing a coefficient of 
variation for fat mass of 3% (unpublished data. Chilibeck, 2003). Chilibeck (2003) 
previously validated this measure by comparing to air displacement plethysmography. 
The correlation between the two techniques for fat mass was 0.98 (Pinkoski et al., 2006). 
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2.3 Procedure 
Upon successful screening following the use of the inclusion/exclusion checklist 
and signing the consent form (Appendix B) women completed a personal information 
form (Appendix E) including such details as date of birth, date of last menstrual period 
and whether or not they have had a hysterectomy. Women were given oral instructions on 
how to complete the questionnaires. Based on the scores of the LTEQ, women were 
placed into quintiles for amount of physical activity (groups 1-lowest to 5-highest) and 
these quintiles were examined for differences in menopausal symptoms. Dividing women 
into 5 groups distinguishes between those who are doing less or more than the 
recommended 30 to 60 minutes of moderate intensity physical activity on most days 
(PHAC, 2007). Using this daily exercise recommendation the weekly exercise duration 
for health benefits would fall between 3.5 to 7 hours of moderate intensity exercise per 
week. The lowest quintile (Group 1) in this study were considered to be the inactive 
women (performing about 30 minutes of moderate intensity physical activity per week), 
and the highest quintile (Group 5) were considered to be the most active (performing 
more than 2 hours of moderate intensity physical activity per week). The women with 
scores in between quintiles 1 and 5 were considered to be intermediately active groups 
(performing between 30 minutes to 2 hours of moderate intensity physical activity per 
week). Therefore only the women in the top fifth quintile in the study were doing enough 
leisure time physical activity to receive optimal health benefits. It can be assumed that 
since 15-minutes is the minimum duration that most leisure activity sessions reported on 
the questionnaire lasted slightly longer, possibly between 20 to 30 minutes. These 
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calculations are averaged and based on the minimum 15-minute sessions; therefore 
activity levels in each group may actually be slightly under reported.  
The activity groups were derived based on scores from the Leisure-Time Exercise 
Questionnaire (Godin & Shephard, 1985). This questionnaire asks the frequency of 
strenuous, moderate and mild exercise lasting longer than 15 minutes during a 7-day 
period. Strenuous exercise is explained as activity that induces a rapid heartbeat with 
exercises including jogging, hockey, soccer, squash, basketball, cross-country skiing, 
judo, and vigorous cycling. Moderate exercise is explained as activity that is not 
exhausting and includes exercises such as fast walking, baseball, tennis, easy cycling, 
volleyball, easy swimming and folk dancing. Mild exercise is explained as requiring 
minimal effort and includes activities such as yoga, bowling, golf and easy walking. The 
participants were divided into quintiles according to their scores on the LTEQ.  Group1 
had LTEQ scores between 0-8, whereas group 5 had scores higher than 38.5.  Table 1 
reflects 5 activity levels and the number of sessions of exercise per week lasting longer 
than 15-minutes in duration at any of the 3 intensities that women completed to fall 
within the range of that activity group. Table 1 also represents the frequency of exercise 
sessions lasting longer than 15-minutes that should be performed throughout the week in 
order to match one of the five activity groups.  This will indicate the approximate amount 
of physical activity women in this study performed and the difference among the five 
activity levels, considering that all women were non-vigorously active upon entering the 
study. 
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Table 1. 
Activity Group LTEQ Score  # of exercise sessions/week lasting > 15 min 
                                                                  Mild Moderate Strenuous 
1 0-8 ~ 3 ~ 2 ~1 
2 9-18 3-6 2- 4 1-2 
3 19-26 6-9 4-5 2-3 
4 27-38 9- 13 5-8 3-4 
5 38.5 + >13 >8 >4 
 
The menopausal index asks the frequency (number of times per week), severity 
(score of 0 to 3, where 0 is no symptoms and 3 is severe), and duration (minutes) of 1) 
hot flashes, 2) insomnia, 3) limb numbness, 4) fatigue and 5) headache. The insomnia 
section of the questionnaire also includes yes/no questions of whether women have 
difficulty falling asleep, difficulty staying asleep and waking too early in the morning. 
The final sections of the questionnaire includes yes/no questions for:  1) psychologically-
related symptoms (i.e. mood changes, depression, irritability, anxiety, and decrease 
concentration), 2) urogenital symptoms (i.e. decreased sexual libido, vaginal dryness, 
uncomfortable intercourse, changes in urinary frequency), and 3) physical symptoms 
(aches and pains in the back, muscles, and joints, breast tenderness, and weight gain). 
Each of these final sections was scored for number of “yes” responses to each symptom, 
where each “yes” response increased the score by 1. The severity and frequency 
responses were converted into Z-scores, and then the mean of the two Z-scores for each 
symptom was calculated to determine an overall Z-score for the symptoms of hot flashes, 
limb numbness, fatigue, and headaches.  For insomnia the overall Z-score was calculated 
by taking the mean of the Z-scores from frequency and severity and the mean of the Z-
scores from the yes/no responses for difficulty falling asleep, difficulty staying asleep and 
waking too early in the morning. The two mean Z-scores were combined to make a total 
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mean Z-score for insomnia. The responses to duration for each symptom were often left 
unanswered therefore we did not have enough data to consider it as an accurate response. 
Other studies have excluded the duration question in their analysis since they also found 
that the responses were inconsistent or incomplete (St. Germain et al., 2001). Finally, the 
yes/no responses for sections on psychological, urogenital, and physical symptoms were 
summed then converted to mean Z-scores representing an overall score for each section. 
 
2.4 Analysis 
The analysis was conducted using SPSS version 14.0. Prior to any data analysis, 
the level of significance was preset at p≤ 0.05. This thesis was based upon secondary data 
analysis from a data set from a clinical trial. This was a cross-sectional study and was 
exploratory in nature.  
First, a MANCOVA was conducted to determine whether higher activity levels 
have an independent effect on menopausal symptom reduction by including potential 
confounders that were different among the groups. Differences among the dependent 
variables were analyzed according to the independent variable of activity levels (i.e. there 
are 5 levels of the independent variable in the one-way MANCOVA).  
Secondly, a one-way MANOVA was conducted looking for symptom differences 
among the 5 activity levels (significant if Wilks’ Lamda p≤ 0.05). The dependent 
variables in the MANOVA were: Z-scores for hot flashes, insomnia, limb numbness, 
fatigue, headache, psychologically-related symptoms, urogenital symptoms and physical 
symptoms. Appropriate univariate tests were conducted. Post-hoc tests (Bonferroni) were 
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used to determine where the group differences existed for each significant menopausal 
symptom. 
There is empirical evidence supporting that years post-menopause, hysterectomy 
(yes=1 or no=0), and percent body fat may have an effect on menopausal symptoms 
therefore may be potential confounding variables.  The purpose of running both the 
MANOVA and the MANCOVA was to determine whether differences between physical 
activity levels are due to the potential confounding variable(s).  
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CHAPTER 3 – RESULTS 
 The mean (SD) age of the participants was 58.2 (6.3) years, the mean years 
postmenopausal was 6.7 (6.0) years and the mean percent body fat was 37.4 (5.6) %. Of 
the 401 in the study, 16.5% had a previous hysterectomy. Other group characteristics can 
be seen in Table 2. 
Table 2.  
PA Level 
N Mean 
Age 
Mean Years 
Menopausal
Mean % Body 
Fat 
Mean % with 
Hysterectomy 
1 82 56.7 (6.3) * 6.6 (5.9) 39.3 (4.6)*** 21 
2 80 57.3 (5.2) 5.9 (4.9) 38.3 (5.9)**** 16 
3 82 59.2 (7.5) 7.1 (6.6) 36.9 (4.9) 17 
4 80 60.1 (5.9)** 7.5 (6.2) 36.9 (5.7) 14 
5 77 58.0 (5.9) 6.3 (6.2) 35.6 (6.0) 14 
Total Mean 80.2 58.2 (6.3) 6.7 (6.0) 37.4 (5.6) 16 
 
* Significantly younger than PA level 3, (p<0.05). 
** Significantly older than PA level 1, 2 & 5, (p<0.05). 
*** Significantly higher than PA level 3, 4 & 5, (p<0.05). 
**** Significantly higher than PA level 5, (p<0.05). 
 
Results of the MANOVA indicated a significant group main effect of physical 
activity on menopausal symptoms {Wilks’ Lamda F(32,1436) = 1.510, p = 0.034}. The 
overall multivariate effect size for the MANOVA was 0.03. Of the 8 symptoms under 
review there were significant group differences for physical symptoms {F(4,396) = 
3.844, p=0.004}and fatigue {F(4,396) = 2.341, p=0.05}. The effect size for both physical 
symptoms and fatigue was 0.31. The post hoc analyses are displayed in Figures 1 and 3. 
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Figure 1. * = Significantly more physical symptom complaints than groups 4 & 5 
Error bars reflect Standard Error 
 
Of the 3 symptoms comprising physical symptoms there was significant 
differences for reported weight gain {F(4,396) = 3.902, p=0.004} but not for breast 
tenderness {F(4,396) = 0.491, p=0.742} or aches and pains {F(4,396) = 1.596, p=0.175}. 
The effect size for weight gain was 0.32. Figure 2 shows the differences in reported 
weight gain among the 5 levels of physical activity. 
 
 
 
 
 
 
 
 
Figure 2. 
 
* = Significantly more weight gain than groups 4 & 5. 
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Figure 3. Error bars reflect Standard Error 
 
 
The post-hoc analysis identified that 2 least active groups reported above average 
fatigue occurrence whereas the 3 most active groups reported below average fatigue 
occurrence.  
There were no significant group differences for insomnia {F(4,396) = 0.698, 
p=0.594}, numbness in limbs {F(4,396) = 0.050, p = 0.995}, psychological symptoms 
{F(4,396) = 0.737, p = 0.567}, or urogenital symptoms {F(4,396) = 0.190, p = 0.944} 
however hot flashes {F(4,396) = 2.242, p=0.064}, and headache {F(4,396) = 2.23, 
p=0.065} were close to p≤ 0.05. The symptom differences across groups are presented in 
Figures 4-9. 
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Figure 4. Error bars reflect Standard Error 
 
 
 
Figure 5. Error bars reflect Standard Error 
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Figure 6.  Error bars reflect Standard Error 
 
 
 
Figure 7.  Error bars reflect Standard Error 
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Figure 8.  Error bars reflect Standard Error 
 
 
 
Figure 9.  Error bars reflect Standard Error 
 
 
There were no significant group differences for hysterectomy {F(4,396) = 0.448, 
p=0.774} or time since menopause {F(4,396) = 0.941, p=0.440}. However there were 
significant group differences for percent body fat {F(4,394) = 5.47, p=0}. Figure 10 
shows the differences in mean percent body fat between groups.  
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Figure 10.  
* Group 1 has significantly higher percent body fat than Groups 3, 4 & 5 
** Group 2 has significantly higher percent body fat than Group 5. 
 
Since percent body fat was the only covariate that was significantly different 
among groups it was the only one included in the MANCOVA. This multivariate test was 
not significant between physical activity groups with percent fat as a covariate {Wilks’ 
Lamda F(32,1425) = 1.295, p = 0.126}.  
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CHAPTER 4 – DISCUSSION 
The present study examined the difference of menopausal symptom reporting 
relative to five activity levels among a sample of non-vigorously active postmenopausal 
women who were not using hormone replacement therapy. This study was a cross-
sectional design and exploratory in nature. When controlling for the group means 
differences of percent body fat there was no independent effect of physical activity on 
menopausal symptoms. However when not accounting for effects of percent body fat 
there were activity level group differences for reporting physical symptoms (only weight 
gain) and fatigue. In other words, when accounting for group differences of percent fat, 
physical activity has no independent effect on menopausal symptoms and it can be 
assumed that any indirect effect of physical activity on menopausal symptoms is through 
an alteration of body fat.  
The results indicate group differences in reported weight gain, which may be 
explained by the relationship between perceived weight gain and percent body fat. Since 
the menopausal transition is associated with weight gain and increased obesity (Lovejoy, 
2003), exercise may play a role in preventing these body composition changes.  Pronk 
and Wing (1994) found physical activity to be a low-risk method of preventing weight 
gain and promoting maintenance of weight loss in overweight and obese women. These 
findings are also in agreement with Irwin et al. (2003) who found that sedentary 
postmenopausal women who exercised for approximately 3 hours a week for a year lost 
significant amount of body fat while maintaining their usual diet. Sternfeld et al. (2005) 
also identified exercise as a beneficial means to maintain optimal body composition. 
41 
Increased body fat may increase fatigue through inefficiency in performing 
everyday activities. Dimeo et al. (1998) found that aerobic training can improve 
performance by reducing rapid fatigability when carrying out daily activities. These study 
results identified similar findings to Mirzaiinjmabadi et al. (2006) who found a positive 
relationship between exercise and reduced tiredness in postmenopausal women.  
This study did not find a significant relationship between hot flashes and activity 
levels. These findings correspond with other studies (Aiello et al., 2004; Nelson et al., 
2007; Mirzaiinjmabadi et al., 2006) that also found no association between activity levels 
and vasomotor symptoms. However many studies have found a positive association 
between exercise and reduced vasomotor symptoms (Progetto Menopausa Italia Study 
Group, 2005; Stadberg et al., 2000; Guthrie et al., 2005; Li et al., 2003; Elavsky & 
McAuley, 2007). Since the most active women (group 5) reported the most hot 
flashes/night sweats and since they had the lowest percent body fat, it is possible that they 
had lower levels of circulating estrone, explaining the increased hot flash reports. Some 
data suggests that heavier women report fewer hot flashes resulting from a fat-related 
increase in circulating estrone (Longcope, 1979; Erlik et al., 1982; Schwingl et al., 1994). 
The least active women (group 1) reported the next highest frequency of hot flashes/night 
sweats. There is a positive association between BMI and vasomotor symptoms (Gold et 
al., 2000; Gold et al., 2006; Li et al., 2003; Ivarsson et al., 1998) where increased 
adiposity raises core body temperature and has been said to increase hot flash frequency 
(Glickman-Weiss, Nelson, Hearon, Prisby,& Caine, 1999); thus one might speculate the 
possibility that the highest reporting of hot flashes in the least active quintile (group 1) in 
this study is related to women in this group being more overweight and having the 
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highest percent body fat (Group 1 mean = 39.3% vs Group 5 mean = 35.6%).  Two cross-
sectional studies identified that women with BMI over 32 kg/m2 had a higher prevalence 
of hot flashes/night sweats than women with a BMI less than 19 kg/m2 (Gold et al., 2000) 
and that a BMI between 25-29.9 was associated with a higher incidence of hot flashes (Li 
et al., 2003). The current study results did not demonstrate a linear relationship between 
activity levels and hot flashes or night sweats. One might speculate that the relationship 
may be parabolic; that is, with low and high levels of physical activity (ie. lower vs 
higher % body fat) resulting in greater hot flashes/night sweats than moderate levels of 
physical activity.  
This study did not find a significant relationship between physical activity and 
headache. Past research has stated that regular aerobic exercise decreases headache 
frequency and severity by as much as 50% (Peterson, 2007). Steiner et al. (2002) found 
that tension headaches are more commonly reported among sedentary individuals, in 
which exercise may be a viable preventative treatment. Since exercise has been shown to 
result in a temporary increase of cortical blood flow and an increase of beta-endorphin 
release (Oleson, 1971) it may dull or numb headache pain. In this study the least active 
group reported the highest frequency of headache whereas the most active group reported 
the least occurrence of headache. Other researchers have found that regular exercise can 
reduce headache (Progetto Menopausa Italia Study Group, 2005; Mirzaiinjmabadi et al., 
2006; Slaven & Lee, 1997). 
Longitudinal studies have shown that higher levels of leisure time physical 
activity are associated with lower risks of depression and depressive symptoms (Dunn et 
al., 2001). This thesis did not identify a significant association between activity levels and 
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psychological symptoms in postmenopausal women. It has been suggested that 
perimenopause is associated with increased reporting of depressive symptoms; however 
when accounting for confounding variables, depression is not associated with 
menopausal status (Bosworth et al., 2001). Bosworth et al. (2001) also reported a 
significant correlation between inactivity and increased depressive symptoms.  The 
findings of this study were contrary to other researchers who have found exercise to 
reduce psychological symptoms during menopause (Mirzaiinjmabadi et al., 2006; Slaven 
& Lee, 1997; Nelson et al., 2007; Progetto Menopausa Italia Study Group, 2005). A 
review by Dunn et al. (2001) identified that both aerobic and resistance exercise can 
reduce symptoms of depression. 
Past research has indicated that exercisers report fewer sleep problems than 
sedentary individuals (Gold et al., 2000; Progetto Menopausa Italia Study Group, 2005; 
Slaven & Lee, 1997). Others, however, have also reported no effect of exercise on sleep 
quality (Elavsky & McAuley, 2007). Elavsky and McAuley (2007) suggested that a four-
month moderate-intensity aerobic exercise intervention may be an insufficient stimulus to 
improve perceived sleep quality in symptomatic menopausal women. The results of this 
thesis do not demonstrate that those with higher activity levels have fewer sleep 
problems. Sleep changes in postmenopausal women have been linked to hot flashes/night 
sweats and to stress (Manber & Armitage, 1999).  
This thesis found no significant relationship between activity levels and limb 
numbness or urogenital symptoms. Of the questions on the Menopausal Index regarding 
urogenital symptoms (decreased libido, vaginal dryness, uncomfortable intercourse and 
changes in urinary frequency) often the questions regarding intercourse and libido were 
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left blank or women reported as not applicable which may have affected the results.  
Ojanlatva et al. (2006) found that strenuous exercise improved orgasm experience in pre-
menopausal women but not in post-menopausal aged women. Although limb numbness is 
included in the menopausal symptom index, it is not commonly described as being a 
menopausal symptom in the menopause literature.  
Percent body fat was the only covariate that was significantly different among the 
five activity groups. It was identified that the women in this study who reported 
performing 4 or fewer sessions of moderate intensity exercise per week lasting a 
minimum of 15-minutes in duration had significantly higher percent body fat those doing 
more than 8 sessions per week. This is consistent with findings of Sternfeld et al. (2005) 
who found that higher levels of physical activity are associated with decreased percent 
body fat. The fact that there is no significant relationship between higher activity levels 
and reduced menopausal symptoms when accounting for differences of percent body fat 
implies that any positive effect of physical activity may be indirectly through a reduction 
in percent body fat. Although the MANOVA was significant without accounting for 
percent fat, the effect size was small. 
These study results can be generalized to non-vigorously active postmenopausal 
women who are not using HRT. The majority of the subjects were middle-class 
Caucasian women. 
This study is unique in that it had a homogenous group of women who were 
considered to be non-vigorously active at the time of recruitment. Perhaps this narrowed 
the ranges in physical activity too much, making it nearly impossible to distinguish 
between activity levels and symptom reporting. HRT use was another exclusion criterion 
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that removed the chance that symptom reduction was occurring as a result of drug 
therapy. Determination of a minimal effective level of physical activity to reduce 
menopausal symptoms cannot be addressed based on these results. 
 
4.1 Conclusion 
In summary, these study results indicate that any effect of physical activity on 
menopausal symptoms is indirectly through the alteration of body composition. Women 
with lower percent body fat report less weight gain and fatigue. There was no significant 
relationship between physical activity levels and reporting of hot flashes/night sweats, 
insomnia, limb numbness, headache, psychological symptoms or urogenital symptoms. 
 
4.2 Limitations 
 The present study was a cross-sectional design therefore it is not possible to 
disprove a causal relationship between activity levels and symptom reduction. This 
design is limited in that it does not verify whether higher levels of physical activity 
reduce menopausal symptoms or whether women who suffer from menopausal symptoms 
have a natural propensity to participate in less physical activity. Since this was secondary 
data analysis there was very little control over the study design and the measurement 
tools.  
Women were included in the study based on self-judgment of whether they were 
vigorously physically active; they were excluded if they admitted to participating in 
weight training, running or high impact aerobic activities. Perhaps excluding women in 
the higher ranges of physical activity may have compromised the ability to identify 
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effects of physical activity on symptoms. A limitation of the LTEQ questionnaire is that 
the number of 15-minute exercise sessions at the different intensities may underestimate 
energy expenditure. Women may have performed 30 to 60 minutes during one exercise 
session but only accounted for 15 minutes as directed by the questionnaire instructions.  
The Menopausal Index by St. Germain et al. (2001) was modified from the 
Kupperman-Blatt Menopausal index. The Kupperman-Blatt index has been criticized by 
Zollner, Acquadro & Schaefer (2005) for weighting factors based on intuitive factors, and 
not on the prevalence and consequence. Zollner et al. (2005) also criticized this 
questionnaire for its lack of quantitative research on psychometric validation finding it to 
be less accurate and sound, when compared to other menopausal questionnaires. Freeman 
et al. (2003) suggested that the Kupperman-Blatt Index was out of date and that it lacked 
statistical justification for summing or weighting item scores or using factor scales. Utian,  
Janata and Kingsberg (2002) criticized the Kupperman-Blatt Index for using ill-defined 
terms, lacking demographic data, having categories with overlapping scores and for 
scores being summed without being based on independent factors. 
Participants were limited from providing additional details that the questionnaire 
may have failed to capture and questionnaire responses may not accurately portray 
individual activity levels or symptoms. For example, a woman may experience headache 
but it may be unrelated to menopause (ie. migraine headaches since childhood) however 
the questionnaire does not allow for clarification. Both questionnaires were based on a 7-
day recall, which may have brought about reporting biases. These results can mainly be 
generalized to middle-class Caucasian women, who made up the majority of the subjects. 
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4.3 Future Directions 
The findings of the present study support exercise not only as a tool to better 
health and disease prevention, but more specifically to reduce some of the negative 
symptoms associated with menopause. A randomized controlled trial is currently 
underway examining the effects of an exercise intervention (ie. weight training 2x/wk 
and walking 4x/wk or stretching 4x/wk), which will include information on menopausal 
symptom reporting. Based on the findings of the study in this thesis, it is recommended 
that future studies match groups based on percent body fat prior to randomization, as 
reduced percent body fat was identified as an outcome of increased activity levels. It is 
also recommended that future studies prescribe a greater amount of physical activity than 
the non-vigorously active women who were recruited for this study. Further research in 
the area of physical activity and its relationship to menopausal symptoms would provide 
a clearer description of the minimum amount of physical activity required to reduce 
menopausal symptoms. 
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Appendix B 
 
Consent Form 
 
Title of the study: Effect of combined exercise therapy and isoflavone supplementation 
on prevention of osteoporosis 
 
Researchers: Philip D. Chilibeck, Ph.D., Associate Professor, College of Kinesiology, 
University of Saskatchewan (966-1072), role: principal researcher; H. Jay Biem, M.D., 
Department of Medicine, Royal University Hospital, University of Saskatchewan (966-
7951), role: clinical trials consultant, Allison Case, M.D., Department of Obstetrics, 
Gynecology and Reproductive Sciences, Royal University Hospital, University of 
Saskatchewan (966-1953), role: medical supervision, uterine ultrasound assessment, 
Olufemi Olantunbosun, M.D., Department of Obstetrics, Gynecology and Reproductive 
Sciences, Royal University Hospital, University of Saskatchewan (966-8033), role: 
medical supervision, uterine ultrasound assessment; Roger Pierson, Ph.D. Department of 
Obstetrics, Gynecology and Reproductive Sciences, Royal University Hospital, 
University of Saskatchewan (966-4458), role: clinical trials consultant, Susan Whiting, 
Ph.D., Professor, College of Pharmacy and Nutrition, University of Saskatchewan (966-
5837), role: nutritional analyses, Punam Pahwa, Assistant Professor, Department of 
Community Health and Epidemiology, University of Saskatchewan (966-7941), role: 
statistical consultant. 
 
Purpose of the study: Exercise training and dietary intake of soy protein increase bone 
mineral density and favorably affect blood cholesterol levels and therefore have the 
potential for preventing osteoporosis and heart disease. The compound in soy protein that 
has a beneficial effect is called a “phytoestrogen”. Phytoestrogens have beneficial effects 
on bone, but unlike estrogen, does not affect breast or endometrial tissue. The purpose of 
this study is to determine the effect of exercise training, phytoestrogen supplementation, 
and combined exercise training and phytoestrogen supplementation on bone mineral 
density, bone quality, body composition, serum lipids, and menopausal symptoms in 
post-menopausal women. 
 
Possible benefits of the study: Possible benefits include an increase in bone mineral 
density, an improvement in bone quality, a loss of body fat, an increase in muscle mass, 
an increase in flexibility, a reduction in cholesterol levels and an improvement in 
menopausal symptoms (i.e. reduction of hot flashes). These benefits are not guaranteed. 
 
Procedures to be followed: You will be randomized to one of four groups: 1) Exercise 
training by weight lifting and brisk walking and phytoestrogen placebo (i.e. you will 
receive a compound that looks like phytoestrogen, but is really an inactive substance); 2) 
Exercise training by flexibility training and phytoestrogen supplementation (90 mg per 
day); 3) Exercise training by weight lifting and brisk walking and phytoestrogen 
supplementation; or 4) Exercise training by flexibility training and phytoestrogen 
placebo. You will have an equal chance of being placed into one of the four groups. The 
study will be double blind, that is, neither you nor the researchers will be aware of 
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whether you are taking phytoestrogen or placebo until the end of the study. You will 
receive 1000 mg of calcium supplement and 20 µg of vitamin D per day throughout the 
study (24 months). If in the weight lifting and brisk walking exercise group, you will be 
required to perform strength training twice per week (45 minutes to an hour each session) 
and brisk walking  four times per week (about 30 minutes each time) for 24 months. If in 
the flexibility training exercise group, you will be required to perform flexibility 
exercises (20-30 minutes per day) four days per week. Your bone mineral density and 
body composition will be measured at entry into the study, at 12 months and again at 24 
months by dual-energy x-ray absorptiometry. The bone in your lower leg and wrist will 
be measured by ultrasound (to measure bone quality) at baseline, 12, and 24 months. 
Blood will be collected at baseline, 12 months and at 24 months for assessment of serum 
lipids. Blood and urine will also be collected at baseline for standard laboratory tests. 
Approximately of 11 mL of blood will be collected at each time point. At baseline and 
after 2 years, a mammogram will be performed for screening of breast cancer and an 
ultrasound will be performed for screening of endometrial cancer. You will be required to 
fill out questionnaires to assess your food intake every 6 months and menopausal 
symptoms every 3 months during the study. You will be required to keep records of your 
physical activity daily. Exercise testing will be performed at baseline, at 12 months and at 
24 months. This will involve determining the maximal amount of weight you can lift on 
several exercises, a walking test over 80 meters, a flexibility test, and a test of balance. 
You will be phoned periodically for two years after the study for assessment of cancers, 
coronary heart disease, lung disease, and stroke. This is to assess whether the 
phytoestrogen is associated with the same risks as regular estrogen. 
 
With your permission, your family physician will be informed of your enrolment and of 
your test results. 
 
Foreseeable risks, side effects and discomfort: There is some radiation exposure with 
the dual energy x-ray absorptiometry and the mammogram. Because these measurements 
are being performed at yearly intervals (dual energy x-ray absorptiometry) or 2 years 
apart (mammogram), the annual exposure is not considered to be a hazardous level. 
 
There is a risk of injury during exercise testing or training. This will be minimized by 
proper warm-up procedures and supervision by qualified exercise trainers. 
 
There will be some discomfort when blood is drawn for testing serum lipids. Bruising or 
infection at the sight of the blood draw is a possibility, but care will be taken to minimize 
these risks. 
The side effects of phytoestrogens are unknown.  
 
There may be unforeseen risks during the study or after the study is completed. 
 
You will be asked to keep a diary card on which you will record any side effects or 
discomfort you may experience from the exercise program or phytoestrogen 
supplementation. 
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You are free to withdraw from the study at any time and this withdrawal will not affect 
access to health care or other services. 
 
Precautions will be taken to protect your anonymity. The data may be published in a 
graduate student thesis or journal article, but you will not be identified and only 
aggregate data will be reported. All data will be stored in a locked office in the College of 
Kinesiology. 
 
There will be no cost to you for participation in this study. You will not be charged for 
the phytoestrogens / placebo, calcium, vitamin D, or any research procedures. In the 
event that you become ill or injured as a result of participation in this study, necessary 
medical treatment will be made available at no additional cost to you. By signing this 
document you do not waive any of your legal rights. 
 
If you have any questions with regard to the research project, you can call Philip 
Chilibeck (966-1072 or 343-6577), Jay Biem (966-7951), Allison Case (966-1953), 
Olufemi Olantunbosun (966-8033), Roger Pierson (966-4458) or Susan Whiting (966-
5037). 
 
If you have any questions about your rights as a research subject, or concerns about your 
participation in this study, you should contact the Chair of the Biomedical Research 
Ethics Board, c/o the Office of Research Services, University of Saskatchewan at (306) 
966-4053. 
 
We will advise you of any new information that will have a bearing on your decision to 
continue in the study. 
 
Alternative treatments: You do not have to participate in this study to increase your 
bone mineral density. Other treatments, including bisphosphonates and standard hormone 
replacement therapy are available for increasing bone mineral density. Blood cholesterol 
levels can be improved by modifying dietary intake of saturated fats. 
 
By signing below, I acknowledge that the study and contents of the consent have been 
explained and that I understand the contents, and that I have received a copy of the 
consent form for my own records. 
 
You will be informed of your results at the completion of the study. Because subjects are 
being staggered into the study and we want to maintain blinding of the study throughout 
its duration, you may not be informed of your results until a couple of years after you 
complete the study. 
 
Date: ____________________________________________________ 
 
Participant Signature: ______________________________________________ 
 
Researcher:________________________________________ 
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Appendix C 
 
LEISURE-TIME EXERCISE QUESTIONNAIRE 
(Godin, Canadian Journal of Applied Sport Sciences 10: 141-146, 1985). 
 
 
1. Considering a 7-day period (a week), how many times on the average do you do the 
following kinds of exercise for more than 15 minutes during your free-time? 
(Write the appropriate number in each box) 
 
 TIMES PER WEEK 
 
a) STRENUOUS EXERCISE (Heart beats rapidly) 
(i.e. running, jogging, hockey, football, soccer, squash, 
basketball, cross-country skiing, judo, roller skating, 
vigorous swimming, vigorous long-distance bicycling). 
? 
  
b) MODERATE EXERCISE (Not exhausting) 
(i.e. fast walking, baseball, tennis, easy bicycling, volley 
ball, badminton, easy swimming, alpine skiing, popular 
and folk dancing). 
? 
  
c) MILD EXERCISE (Minimal effort) 
(i.e. yoga, archery, bowling, horseshoes, golf, snow-
mobiling, easy walking) ? 
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Appendix D 
 
MENOPAUSAL SYMPTOMS QUESTIONNAIRE 
 
Menopausal Index (7-day recall) (St. Germain et al., Menopause 8: 17-26, 2001). 
 
 
Hot flushes/Night sweats 
 
1. How frequently do you have hot flushes and/or night sweats? _____ (# per week) 
2. How long do they last?     ______  (minutes) 
3. Rate Severity: 
___ 0 = no symptoms 
___ 1 = mild (uncomfortable – fanning to alleviate symptoms) 
___ 2 = moderate (warrants removal or changing of clothing or cooling ambient 
temperature) 
___ 3 = severe (warrant removal/changing of clothing and cooling ambient 
temperature) 
 
Insomnia 
 
1. How often do you have insomnia?     ______ (# per week) 
2. How long does it last each night?    ______   (minutes) 
3. Rate Severity:  
___ 0 = no symptoms 
___ 1 = mild (tossing and turning in bed) 
___ 2 = moderate (alert enough to get up and have a drink or go to the bathroom) 
___ 3 = severe (Alert enough to read or work) 
4. Answer Yes or No to each of the following: 
 a. Do you have difficulty going to sleep?   ______    
 b. Do you have difficulty staying asleep?   ______    
 c. Do you wake up too early in the morning?   ______    
 
Numbness (pins and needles) in limbs 
 
1. How frequently do you have numbness in your limbs? ______ (# per week) 
2. How long does it last?      ______ (minutes) 
3. Rate Severity:  
___ 0 = no symptoms 
___ 1 = mild (slight tingling in extremities) 
___ 2 = moderate (partial numbness with ability to move extremities) 
___ 3 = severe (complete numbness, similar to having foot fall asleep) 
 
 
(turn page over)
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Fatigue 
  
1. Frequency        ______ (# per week) 
2. Duration       ______  (minutes) 
3. Rate Severity 
___ 0 = no symptoms 
___ 1 = mild (slight feeling of fatigue during the day) 
___ 2 = moderate (trouble staying awake, i.e. nodding off during the day) 
___ 3 = severe (need to go to bed during the day or early evening) 
 
Headaches 
 
1. How frequent do you get headaches?     ______ (# per week) 
2. How long do your headaches last?    ______  (minutes) 
3. Rate Severity:  
___0 = no symptoms 
___1 = mild (minor annoyance/inconvenience) 
___2 = moderate (warrants taking pain medication) 
___3 = severe (extreme enough to take pain medication and go to bed) 
 
Please answer Yes or No to the following symptoms: 
 
1. Mood changes     ______   
2. Depression     ______   
3. Irritability     ______   
4. Anxiety     ______   
5. Decreased concentration   ______   
6. Decreased sexual desire (libido)  ______   
7. Vaginal dryness    ______   
8. Uncomfortable intercourse   ______   
9. Changes in urinary frequency   ______   
10. Aches and pains (backache, muscle, joint) ______   
11. Breast tenderness    ______   
12. Weight gain     ______   
13. Changes in bleeding pattern   ______   
(intensity, duration, etc.) during past 6 weeks 
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Appendix E 
 
Subject Information Sheet 
 (Use black ink only) For office use only  
Subject’s Initials 
 
Recruitment # 
 
Name:______________________________________________________ 
 (first)   (middle initial)  (Last) 
 
Birth Date_______________      
           (day/month/year) 
  
HSP # ___________________________________ 
Address:__________________________________ 
_________________________________________ 
_________________________________________ 
Email:_____________________________  
 
Phone: (h) _________________  (w)_________________  Other:_______________     
Family Physician: _____________________   Phone Number: _____________________ 
 
Approximate Date of Last Menstrual Period:_______________________       
Hysterectomy:      ? Yes             No ?  
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Appendix F: SPSS Output 
One way ANOVA – Confirming possible confounding variables 
 
ANOVA
MonthsMenopausal
19411.280 4 4852.820 .941 .440
2042687 396 5158.301
2062098 400
Between Groups
Within Groups
Total
Sum of
Squares df Mean Square F Sig.
 
ANOVA
Hysterectomy
.248 4 .062 .448 .774
54.889 396 .139
55.137 400
Between Groups
Within Groups
Total
Sum of
Squares df Mean Square F Sig.
 
ANOVA
PercentFat
651.714 4 162.929 5.470 .000
11736.233 394 29.787
12387.948 398
Between Groups
Within Groups
Total
Sum of
Squares df Mean Square F Sig.
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MANCOVA (% fat) OUTPUT 
 
Between-Subjects Factors
81
80
82
80
76
1.00
2.00
3.00
4.00
5.00
PALevel5
N
 
 
Multivariate Testsc
.097 5.189a 8.000 386.000 .000
.903 5.189a 8.000 386.000 .000
.108 5.189a 8.000 386.000 .000
.108 5.189a 8.000 386.000 .000
.099 5.294a 8.000 386.000 .000
.901 5.294a 8.000 386.000 .000
.110 5.294a 8.000 386.000 .000
.110 5.294a 8.000 386.000 .000
.104 1.298 32.000 1556.000 .124
.900 1.295 32.000 1425.093 .126
.107 1.292 32.000 1538.000 .128
.043 2.068b 8.000 389.000 .038
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Effect
Intercept
PercentFat
PALevel5
Value F Hypothesis df Error df Sig.
Exact statistica. 
The statistic is an upper bound on F that yields a lower bound on the significance level.b. 
Design: Intercept+PercentFat+PALevel5c. 
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MANOVA OUTPUT 
Between-Subjects Factors
82
80
82
80
77
1.00
2.00
3.00
4.00
5.00
PALevel5
N
 
Multivariate Testsc
.000 .002a 8.000 389.000 1.000
1.000 .002a 8.000 389.000 1.000
.000 .002a 8.000 389.000 1.000
.000 .002a 8.000 389.000 1.000
.119 1.509 32.000 1568.000 .034
.885 1.510 32.000 1436.156 .034
.125 1.510 32.000 1550.000 .034
.061 2.991b 8.000 392.000 .003
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Pillai's Trace
Wilks' Lambda
Hotelling's Trace
Roy's Largest Root
Effect
Intercept
PALevel5
Value F Hypothesis df Error df Sig.
Exact statistica. 
The statistic is an upper bound on F that yields a lower bound on the significance level.b. 
Design: Intercept+PALevel5c. 
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Tests of Between-Subjects Effects
6.825a 4 1.706 2.242 .064
1.995b 4 .499 .698 .594
.169c 4 .042 .050 .995
7.634d 4 1.909 2.341 .054
5.900a 4 1.475 2.230 .065
2.942b 4 .735 .737 .567
.771e 4 .193 .190 .944
14.797f 4 3.699 3.844 .004
.001 1 .001 .001 .975
.000 1 .000 .001 .981
.002 1 .002 .003 .958
.000 1 .000 .000 .985
.002 1 .002 .003 .956
.000 1 .000 .000 .986
.003 1 .003 .003 .960
.003 1 .003 .003 .957
6.825 4 1.706 2.242 .064
1.995 4 .499 .698 .594
.169 4 .042 .050 .995
7.634 4 1.909 2.341 .054
5.900 4 1.475 2.230 .065
2.942 4 .735 .737 .567
.771 4 .193 .190 .944
14.797 4 3.699 3.844 .004
301.397 396 .761
282.891 396 .714
337.756 396 .853
322.836 396 .815
261.871 396 .661
395.372 396 .998
401.729 396 1.014
381.053 396 .962
308.222 401
284.887 401
337.927 401
330.471 401
267.771 401
398.314 401
402.502 401
395.850 401
308.222 400
284.887 400
337.925 400
330.471 400
267.771 400
398.314 400
402.500 400
395.850 400
Dependent Variable
FlushFSMeanZ
InsFSMEANZ
NumbFSMEANZ
FatigueFSMEANZ
HeadFSMEANZ
PsychMeanZscore
SexMeanZscore
PhysicalMeanZscore
FlushFSMeanZ
InsFSMEANZ
NumbFSMEANZ
FatigueFSMEANZ
HeadFSMEANZ
PsychMeanZscore
SexMeanZscore
PhysicalMeanZscore
FlushFSMeanZ
InsFSMEANZ
NumbFSMEANZ
FatigueFSMEANZ
HeadFSMEANZ
PsychMeanZscore
SexMeanZscore
PhysicalMeanZscore
FlushFSMeanZ
InsFSMEANZ
NumbFSMEANZ
FatigueFSMEANZ
HeadFSMEANZ
PsychMeanZscore
SexMeanZscore
PhysicalMeanZscore
FlushFSMeanZ
InsFSMEANZ
NumbFSMEANZ
FatigueFSMEANZ
HeadFSMEANZ
PsychMeanZscore
SexMeanZscore
PhysicalMeanZscore
FlushFSMeanZ
InsFSMEANZ
NumbFSMEANZ
FatigueFSMEANZ
HeadFSMEANZ
PsychMeanZscore
SexMeanZscore
PhysicalMeanZscore
Source
Corrected Model
Intercept
PALevel5
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .022 (Adjusted R Squared = .012)a. 
R Squared = .007 (Adjusted R Squared = -.003)b. 
R Squared = .001 (Adjusted R Squared = -.010)c. 
R Squared = .023 (Adjusted R Squared = .013)d. 
R Squared = .002 (Adjusted R Squared = -.008)e. 
R Squared = .037 (Adjusted R Squared = .028)f. 
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Post Hoc Tests 
Multiple Comparisons
Bonferroni
.0300 .14189 1.000 -.3705 .4306
.2948 .14101 .372 -.1032 .6929
.3126 .14189 .282 -.0879 .7131
.2747 .14328 .559 -.1298 .6792
-.0300 .14189 1.000 -.4306 .3705
.2648 .14189 .627 -.1357 .6653
.2826 .14276 .485 -.1204 .6856
.2447 .14415 .904 -.1622 .6516
-.2948 .14101 .372 -.6929 .1032
-.2648 .14189 .627 -.6653 .1357
.0178 .14189 1.000 -.3828 .4183
-.0201 .14328 1.000 -.4246 .3843
-.3126 .14189 .282 -.7131 .0879
-.2826 .14276 .485 -.6856 .1204
-.0178 .14189 1.000 -.4183 .3828
-.0379 .14415 1.000 -.4448 .3690
-.2747 .14328 .559 -.6792 .1298
-.2447 .14415 .904 -.6516 .1622
.0201 .14328 1.000 -.3843 .4246
.0379 .14415 1.000 -.3690 .4448
-.1053 .15415 1.000 -.5404 .3299
.2904 .15320 .588 -.1421 .7228
.3709 .15415 .166 -.0642 .8061
.3296 .15567 .349 -.1098 .7690
.1053 .15415 1.000 -.3299 .5404
.3956 .15415 .106 -.0395 .8308
.4762* .15510 .023 .0384 .9140
.4348 .15660 .058 -.0072 .8769
-.2904 .15320 .588 -.7228 .1421
-.3956 .15415 .106 -.8308 .0395
.0806 .15415 1.000 -.3546 .5157
.0392 .15567 1.000 -.4002 .4786
-.3709 .15415 .166 -.8061 .0642
-.4762* .15510 .023 -.9140 -.0384
-.0806 .15415 1.000 -.5157 .3546
-.0414 .15660 1.000 -.4834 .4007
-.3296 .15567 .349 -.7690 .1098
-.4348 .15660 .058 -.8769 .0072
-.0392 .15567 1.000 -.4786 .4002
.0414 .15660 1.000 -.4007 .4834
(J) PALevel5
2.00
3.00
4.00
5.00
1.00
3.00
4.00
5.00
1.00
2.00
4.00
5.00
1.00
2.00
3.00
5.00
1.00
2.00
3.00
4.00
2.00
3.00
4.00
5.00
1.00
3.00
4.00
5.00
1.00
2.00
4.00
5.00
1.00
2.00
3.00
5.00
1.00
2.00
3.00
4.00
(I) PALevel5
1.00
2.00
3.00
4.00
5.00
1.00
2.00
3.00
4.00
5.00
Dependent Variable
FatigueFSMEANZ
PhysicalMeanZscore
Mean
Difference
(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval
Based on observed means.
The mean difference is significant at the .05 level.*. 
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ANOVA
WeightGain
3.689 4 .922 3.902 .004
93.593 396 .236
97.282 400
Between Groups
Within Groups
Total
Sum of
Squares df Mean Square F Sig.
 
 
Multiple Comparisons
Dependent Variable: WeightGain
Bonferroni
-.054 .076 1.000 -.27 .16
.061 .076 1.000 -.15 .28
.209 .076 .066 -.01 .42
.152 .077 .494 -.07 .37
.054 .076 1.000 -.16 .27
.115 .076 1.000 -.10 .33
.263* .077 .007 .05 .48
.206 .078 .083 -.01 .43
-.061 .076 1.000 -.28 .15
-.115 .076 1.000 -.33 .10
.148 .076 .541 -.07 .36
.091 .077 1.000 -.13 .31
-.209 .076 .066 -.42 .01
-.263* .077 .007 -.48 -.05
-.148 .076 .541 -.36 .07
-.056 .078 1.000 -.28 .16
-.152 .077 .494 -.37 .07
-.206 .078 .083 -.43 .01
-.091 .077 1.000 -.31 .13
.056 .078 1.000 -.16 .28
(J) PALevel5
2.00
3.00
4.00
5.00
1.00
3.00
4.00
5.00
1.00
2.00
4.00
5.00
1.00
2.00
3.00
5.00
1.00
2.00
3.00
4.00
(I) PALevel5
1.00
2.00
3.00
4.00
5.00
Mean
Difference
(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval
The mean difference is significant at the .05 level.*. 
 
 
 
 
 
 
73 
Appendix G:  
Literature Review Grid 
Authors/Year Objective Design Population Major Findings 
Nelson, Sammel, 
Freeman, Lin, 
Gracia, & Schmitz, 
2007 
 
- determine whether PA 
decreases risk of  
menopausal symptoms 
among African American 
and Caucasian women 
 
9-yr non-
randomized 
prospective 
observational 
study 
N=380 
Ages: 35-47 
- walking 4.0 mph for 1.5 h, five times a 
week, associated with lower levels of 
stress 
- No relationship between PA and 
vasomotor symptoms 
- Suggest that maintaining or increasing PA 
during the menopausal transitional period 
and postmenopause may assist in reducing 
a variety of psychological symptoms, 
including anxiety, stress, and depression. 
Elavsky & 
McAuley, 2007 
- evaluate effects of 4-
month moderate-intensity 
walking and low-intensity 
yoga interventions on self-
reported sleep quality  
Randomized 
control trial 
N= 164  
Ages: 42-58 
Mean age: 49.9 
- walking and low-intensity yoga programs 
were ineffective in yielding statistically 
significant improvements in sleep quality 
Elavsky & 
McAuley, 2007 
Effects of 4-mo walking 
and yoga intervention on 
mental health and QOL 
Randomized 
control trial 
N= 164  
Ages: 42-58 
Mean age: 49.9 
- PA enhances mood and menopause-related 
QOL  
- Cardio fitness may reduce symptoms 
Mirzaiinjmabadi, 
Anderson, & Barnes, 
2006 
Examine relationship 
between exercise and BMI 
on menopausal symptoms 
Cross-sectional N= 886  
Ages: 45-60 yrs  
Australian 
women 
- relationship exists between somatic 
symptoms, psychological symptoms, 
depression and anxiety 
- No relationship between exercise and 
vasomotor symptoms & sexual function  
- Exercise effective in relieving somatic and 
psychological symptoms, including 
depression and anxiety. 
- relationship between exercise and feeling 
tired, psychological symptoms, headache, 
limb numbness 
- no relationship between BMI and 
menopausal symptoms 
Progetto Menopausa 
Italia Study Group, 
2005 
identify correlates of 
climacteric symptoms in 
women around menopause 
attending menopause 
clinics in Italy 
Cross-sectional N= 66,501 
Mean age: 54.4 
yrs 
 
- Lower PA associated with depression, 
difficulties to sleep, forgetfulness, 
irritability 
- hot flashes/night sweats more common in 
women with higher BMI and reporting 
lower levels of PA 
- Women, who performed regular exercise, 
experienced less frequent depression, 
headache, urinary leakage, irritability, hot 
flashes/night sweats, forgetfulness and 
difficulty to sleep.  
- Minimal physical activity associated with 
higher BMI than women who performed 
regular physical activity. 
Guthrie, 
Dennerstein, Taffe, 
Lehert, & Burger, 
2005 
investigate factors 
associated with the 
presence, severity, and 
frequency of hot 
flushes 
9-yr non-
randomized 
prospective 
observational 
study 
N= 381 
- Australian 
women 
- Ages: 45-55 yrs 
- Menopause status, FSH and estradiol 
levels, age, exercise level, and smoking 
status all contributed to the experience of 
bothersome hot flushes. 
Villaverde-
Gutierrez,Araujo, 
Cruz, Roa, Barbosa, 
& Ruiz-Villaverde, 
2006  
Examine effects of 
physical exercise on QOL 
in menopausal women 
Quasi-
experimental study 
with random 
assignment 
 
N = 48 
Ages: 55-72 yrs 
 
- women meno symptoms and HRQOL 
worsened 
 
Aiello, Yasui, 
Tworoger, Ulrich, 
Irwin, Bowen, et al., 
2004 
evaluate the effect of 
moderate-intensity 
exercise on the occurrence 
and severity 
of menopause symptoms 
Randomized 
control trial  
N= 173 
Mean Age: 
60.7yrs 
Overweight, 
postmenopausal  
- Exercise does not seem to decrease the 
risk of having menopause symptoms in 
overweight, postmenopausal women not 
taking hormone therapy  
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Li, Samsioe, 
Borgfeldt, Lidfeldt, 
Agardh, & 
Nerbrand, 2003 
analyze influence of 
sociodemographic 
characteristics and 
environmental factors on 
self-reported menopause-
related symptoms among 
middle-aged women 
 
Population based 
survey 
N=6917 
Swedish women 
Mean age: 56 
Age range = 50-
64 
- higher incidence of flashes for women 
who report weight gain (BMI b/w 25-30) 
- vigorous PA associated with less vaginal 
dryness, lower intensity flashes 
- weight gain major risk factor for 
aggravation of  menopausal symptoms 
- weight gain increased the risk of hot 
flushes by 30% - 38%, 
- Menopausal symptoms may commence 
earlier and be of longer duration in obese 
women. 
Li & Holm; 2003 to examine the influence 
of PA alone and in 
combination with HRT on 
vasomotor symptoms at 
menopause 
to identify factors that are 
predictive of vasomotor 
symptoms 
Cross-sectional  
 
N= 239  
Mean Age: 54.7 
yrs 
 
- inactive women without HRT experienced 
MORE vasomotor symptoms than women 
with HRT, regardless of PA levels.  
- PA may be synergistic to HRT 
- active women tended to report fewer 
vasomotor symptoms than inactive women 
Gold, Sternfeld, 
Kelsey, Brown, 
Mouton, Neame, 
Salamone, & 
Stellato, 2000 
to investigate relations of 
a limited number of risk 
factors and health 
outcomes 
 
Cross sectional 
study community 
based survey 
N = 12,425 
Ages: 40-45 yrs 
Mostly pre/peri 
menopause 
- Japanese and Chinese women report least 
symptoms 
- African American women complain more 
of vasomotor symptoms and vaginal 
dryness, but less complaints of urine 
leakage and difficulty sleeping  than 
Caucasian women 
- High BMI associated with increased hot 
flash/night sweats, urine leakage and 
stiff/soreness 
Stadberg, Mattsson 
& Milsom, 2000 
investigate factors 
associated 
with climacteric 
symptoms and the use of 
HRT 
- Cross sectional 
 
N= 4504 
Ages: 46-62 yrs 
Swedish women 
- Women with a higher education and 
regular exercise = more often symptom-
free.  
- 69% of 54 yr olds report flashes 
- 50% of 62 yr olds still report vasomotor 
symptoms 
- 52% reported sleeping problems 
- 37% reported decreased libido 
 
Ivarsson, Spetz, & 
Hammar, 1998 
Assess whether physically 
active women have fewer 
vasomotor symptoms than 
sedentary women 
Cross sectional N = 793  
Ages 55-56 
Swedish women 
- Exercise promotes Beta-endophine release 
which stabilizes thermoregulation 
- Women who exercise have fewer 
vasomotor symptoms 
- No difference between hot flash frequency 
for high and low BMI 
Slaven & Lee, 
1997 
Study 1: Examine effects 
of exercise on menopausal 
symptom reporting 
 
Cross sectional 
survey 
 
N= 220 
 
- Exercisers report fewer symptoms than 
non-exercisers 
- Exercising menopausal women experience 
less menopausal distress 
Slaven & Lee, 
1997 
Study 2: Examine mood 
and symptom reporting on 
regular exercisers before 
and after exercise sessions 
Completed 
questionnaire 
before and after 
fitness class 
N= 47 
 
- Enhancements in mood and reduction in 
reported somatic and vasomotor symptoms 
immediately following aerobic class 
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